Skip Navigation

COVID-19 Update

Find a Doctor

Find a Researcher

Researchers

Stacy Lorine Cooper, M.D.

Photo of Dr. Stacy Lorine Cooper, M.D.
  • Director, Pediatric Hematology/Oncology Fellowship Program
  • Assistant Professor of Oncology
Female

Expertise

Cancer, Leukemia, Pediatric Lymphomas, Pediatrics

Research Interests

Pediatric acute lymphoblastic leukemia (ALL); Pediatric acute myeloid leukemia (AML)

Request an Appointment

Insurance Information

Maryland

410-955-8751

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-955-8751
1800 Orleans St.
The Charlotte R. Bloomberg Children's Center Building, 11th Floor
Baltimore, MD 21287 map

The Bunting Blaustein Cancer Research Building

1650 Orleans Street
Baltimore, MD 21287 map
Phone: 410-955-8817

Background

Dr. Stacy Cooper is a pediatric cancer specialist in Baltimore, caring for patients with leukemia and pediatric lymphomas. Dr. Cooper serves as Director of the Pediatric Hematology/Oncology Fellowship Program, Co-Director of the Pediatric Hematologic Malignancy Program and Clinical Director of the Pediatric Oncology Inpatient Program at the Johns Hopkins School of Medicine.

Dr. Cooper received her undergraduate degree in biology and Spanish at the University of Notre Dame. She earned her M.D. at SUNY Upstate Medical University. She completed her residency at the Johns Hopkins School of Medicine, where she also performed a fellowship in pediatric hematology-oncology. Dr. Cooper joined the Johns Hopkins faculty in 2016.

Her research interests include developing novel therapies for acute myeloid leukemia (AML) and other pediatric leukemias. She serves as principal investigator for two national clinical trials in pediatric acute lymphoblastic leukemia (ALL).

Dr. Cooper is a member of the American Board of Pediatrics, the American Society of Hematology, the American Society of Pediatric Hematology Oncology and the Association of Pediatric Program Directors.

...read more

Titles

  • Director, Pediatric Hematology/Oncology Fellowship Program
  • Co-Director, Pediatric Hematologic Malignancy Program
  • Clinical Director, Pediatric Oncology Inpatient Program
  • Assistant Professor of Oncology
  • Instructor of Pediatrics

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD, SUNY Upstate Medical University (2008)

Residencies

  • Johns Hopkins University School of Medicine / Pediatrics (2011)

Fellowships

  • Johns Hopkins University School of Medicine / Pediatric Hematology-Oncology (2015)

Additional Training

  • Medical License, Maryland Board of Physicians (2008)

Research & Publications

Clinical Trial Keywords

B-cell acute lymphoblastic leukemia, Pediatric acute lymphoblastic leukemia, Pediatric acute myeloid leukemia

Clinical Trials

A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL

Selected Publications

Cohen G. Cooper, SL, Young DJ, Bowen CJ, Arwood NM, Poggi SG, Brown PA. "Allopurinol Use During Pediatric Acute Lymphoblastic Leukemia Maintenance Therapy Safely Corrects Skewed 6-Mercaptopurine Metabolism, Improving Inadequate Myelosuppression and Reducing Gastrointestinal Toxicity." Pediatric Blood and Cancer. 2020 January. Accepted

Ruble K, Paré-Blagoev J, Cooper SL, & LA Jacobson. "Pediatric Oncology Provider Perspectives and Practices: Supporting Patients and Families in Schooling After Cancer Diagnosis." Pediatric Blood and Cancer. 2020 January. Online ahead of print.

Ruble K, Paré-Blagoev J, Cooper SL, & LA Jacobson. "Assessment of Online Resources for Returning to School During and After Treatment of Childhood Cancer." Journal of Cancer Education. 2019 May 3. PMID: 31049872

Cooper SL. Young DJ, Bowen CJ, Arwood NM, Poggi SG, Brown PA. "Universal Premedication and Therapeutic Drug Monitoring for Asparaginase-Based Therapy Prevents Infusion-Associated Acute Adverse Events and Drug Substitutions." Pediatric Blood and Cancer. 2019 Aug;66(8):e27797. PMID: 31099154

Ruble K, Paré-Blagoev J, Cooper SL, Martin A, & LA Jacobson. "Parent perspectives on oncology provider communication regarding neurocognitive impacts of cancer therapy and school re-entry." Pediatric Blood and Cancer. 2018 Aug 29:e27427. PMID: 30160071

Contact for Research Inquiries

Bunting-Blaustein Cancer Research Bldg
1650 Orleans St
Room 2M49
Baltimore, MD 21287 map

Academic Affiliations & Courses

Courses and Syllabi

  • Genes to Society (preclinical curriculum) faculty
    2017
  • Foundations of Neoplasia (Johns Hopkins School of Nursing)
    2017
  • Pediatric Oncology Student Interest Group, POPSICLE
    2014
  • Pediatric PRECEDE Faculty (Johns Hopkins School of Medicine)
    2014
  • Director, Inpatient pediatric oncology medical student advanced elective,
    2013
  • Longitudinal Clerkship Faculty
    2013

Activities & Honors

Honors

  • Johns Hopkins/NIH Pediatric Hematology-Oncology Fellowship Teaching Award, 2019
  • Director’s Teaching Award, Sidney Kimmel Comprehensive Cancer Center, 2019
  • Alpha Omega Alpha Honor Society, Alpha Omega Alpha Honor Society, 2007
  • Gold Humanism Honor Society, SUNY Upstate Medical University, 2007

Memberships

  • Association of Pediatric Program Directors, 2015
  • American Society of Pediatric Hematology/Oncology, 2015
  • American Board of Pediatrics, 2013
  • American Society of Hematology, 2012

Professional Activities

  • Chair of Subcommittee on Early Stage Guidelines, National Comprehensive Cancer Network Pediatric Hodgkin Committee, 2019
  • Professional Development Committee, American Society of Pediatric Hematology Oncology, 2020

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button